Table 4 Secondary outcome measures

PSQI Overall

370

4.25 (3.00)

183

4.14 (3.14)

87

0.34

−0.37 to 1.06

100

0.08

−0.60 to 0.77

WPAI % work time missed due to allergy

258

1.66 (9.57)

133

2.23 (12.57)

62

−1.31

−4.23 to 1.61

63

−1.10

−4.02 to 1.82

WPAI % impairment while working due to allergy

273

18.06 (16.55)

143

16.99 (16.79)

65

1.33

−3.53 to 6.20

65

3.09

−1.80 to 7.98

WPAI % overall work impairment due to allergy

255

18.93 (18.27)

131

17.88 (19.29)

62

1.67

−3.86 to 7.21

62

2.43

−3.13 to 7.98

WPAI % class time missed due to allergy

55

1.97 (5.99)

27

1.36 (4.09)

16

1.30

−2.80 to 5.40

12

−1.14

−5.98 to 3.70

WPAI % impairment in the classroom due to allergy

61

17.05 (17.16)

31

16.77 (18.51)

16

−5.33

−15.89 to 5.24

14

−0.81

−12.91 to 11.28

WPAI % overall classroom impairment due to allergy

55

17.37 (17.73)

27

16.44 (17.96)

16

−2.96

−14.69 to 8.76

12

1.02

−12.83 to 14.87

WPAI % activity impairment due to allergy

425

20.16 (16.86)

215

18.42 (16.95)

100

3.20

−0.77 to 7.16

110

3.24

−0.62 to 7.09

Number of work days lost in the previous 3 months due to AR

297

0.78 (3.12)

151

0.59 (1.75)

70

0.55

−0.36 to 1.45

76

0.37

−0.51 to 1.25

Number of PCP visits, as reported by patient, in the previous 3 months

436

2.06 (1.72)

220

1.95 (1.36)

102

0.13

−0.27 to 0.53

114

0.23

−0.16 to 0.62

Number of specialist visits as reported by patient, in the previous 3 months

437

0.96 (1.37)

220

0.88 (1.24)

103

0.15

−0.16 to 0.47

114

0.09

−0.21 to 0.40

Number of PCP visits, as reported by physician, in the previous 3 months

283

2.22 (1.04)

144

2.19 (0.98)

66

0.09

−0.21 to 0.38

73

−0.12

−0.40 to 0.17

Number of specialist visits as reported by physician, in the previous 3 months

153

2.28 (1.32)

76

2.16 (1.18)

36

0.37

−0.13 to 0.87

41

0.17

−0.30 to 0.65

Number of non-prescribed (OTC) drugs over the previous 4 weeks

437

0.24 (0.53)

220

0.19 (0.45)

103

0.05

−0.06 to 0.19

114

0.12

0.01 to 0.23*